Parl FF - Search Results

1

Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer.

Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, Moore JH. Ritchie MD, et al. Among authors: parl ff. Am J Hum Genet. 2001 Jul;69(1):138-47. doi: 10.1086/321276. Epub 2001 Jun 11. Am J Hum Genet. 2001. PMID: 11404819 Free PMC article.

2

Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood.

Yaich L, Dupont WD, Cavener DR, Parl FF. Yaich L, et al. Among authors: parl ff. Cancer Res. 1992 Jan 1;52(1):77-83. Cancer Res. 1992. PMID: 1345763

3

Genomic DNA analysis of the estrogen receptor gene in breast cancer.

Parl FF, Cavener DR, Dupont WD. Parl FF, et al. Breast Cancer Res Treat. 1989 Oct;14(1):57-64. doi: 10.1007/BF01805976. Breast Cancer Res Treat. 1989. PMID: 2575000

4

Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk.

Dupont WD, Page DL, Rogers LW, Parl FF. Dupont WD, et al. Among authors: parl ff. Cancer. 1989 Mar 1;63(5):948-57. doi: 10.1002/1097-0142(19890301)63:5<948::aid-cncr2820630527>3.0.co;2-u. Cancer. 1989. PMID: 2914301

5

Discrepancies of the biochemical and immunohistochemical estrogen receptor assays in breast cancer.

Parl FF, Posey YF. Parl FF, et al. Hum Pathol. 1988 Aug;19(8):960-6. doi: 10.1016/s0046-8177(88)80013-3. Hum Pathol. 1988. PMID: 3402985

6

Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading.

Parl FF, Schmidt BP, Dupont WD, Wagner RK. Parl FF, et al. Cancer. 1984 Nov 15;54(10):2237-42. doi: 10.1002/1097-0142(19841115)54:10<2237::aid-cncr2820541029>3.0.co;2-v. Cancer. 1984. PMID: 6488142

7

A retrospective cohort study of Histologic risk factors in breast cancer patients.

Parl FF, Dupont WD. Parl FF, et al. Cancer. 1982 Dec 1;50(11):2410-6. doi: 10.1002/1097-0142(19821201)50:11<2410::aid-cncr2820501128>3.0.co;2-5. Cancer. 1982. PMID: 7139534

8

Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.

Roodi N, Bailey LR, Kao WY, Verrier CS, Yee CJ, Dupont WD, Parl FF. Roodi N, et al. Among authors: parl ff. J Natl Cancer Inst. 1995 Mar 15;87(6):446-51. doi: 10.1093/jnci/87.6.446. J Natl Cancer Inst. 1995. PMID: 7861463

9

p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.

O'Malley FP, Vnencak-Jones CL, Dupont WD, Parl F, Manning S, Page DL. O'Malley FP, et al. Lab Invest. 1994 Jul;71(1):67-72. Lab Invest. 1994. PMID: 8041120

10

Microsatellite instability and loss of heterozygosity in breast cancer.

Yee CJ, Roodi N, Verrier CS, Parl FF. Yee CJ, et al. Among authors: parl ff. Cancer Res. 1994 Apr 1;54(7):1641-4. Cancer Res. 1994. PMID: 8137273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters